Corcept (CORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Corcept (CORT) shares have started gaining and ...

If modern, durable, and affordable are three words that matter to you when buying furniture, Castlery should be on your radar. The direct-to-consumer company oversees the building, shipping ...

In a cozy backstage lounge decorated with plush velvet lounge chairs from Cort Furniture’s Royal Velvet Collection, presenters and winners can pose with an eight-foot Emmy statue surrounded by ...

In another article, we discussed Corcept Therapeutics Incorporated (NASDAQ:CORT) and shared ClearBridge Small Cap Value Strategy’s views on the company in the previous quarter. In addition ...

Our evaluations and opinions are not influenced by our advertising relationships, but we may earn a commission from our partners’ links. This content is created by TIME Stamped, under TIME’s ...

They really made the place beautiful." We at CBS Essentials love furniture with different functionalities. Not only is this ottoman the perfect place to kick up your feet at the end of the day ...

Corcept Therapeutics (CORT) shares soared 6.5% in the last trading ... This compares to the stock's 15.7% gain over the past four weeks. The company’s sole marketed drug, Korlym, approved ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

I will never buy another piece of furniture from this company. They sent me a pieces of furniture they knew were damaged and hoped I would accept them. Then they tried to replace the damaged ...

Canaccord Genuity maintained its Buy rating and $78.00 price target for NASDAQ:CORT, Corcept Therapeutics (NASDAQ:CORT). The firm highlighted the company's solid performance as the third quarter comes ...

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe ...